https://www.groupelslpharma.com/actualites-article/loratadine-10-mg-en-marque-priv%C3%A9e-pour-juno-otc 2026-04-09 https://www.groupelslpharma.com/actualites-article/loratadine-10-mg- 2026-04-09 https://www.groupelslpharma.com/actualites-article/stock-option-grants 2026-04-08 https://www.groupelslpharma.com/actualites-article/octroi-d'options-d'achat-d'actions 2026-04-08 https://www.groupelslpharma.com/actualites-article/lsl-pharma-fda-approved! 2026-04-08 https://www.groupelslpharma.com/actualites-article/groupe-lsl-approuv%C3%A9-fda! 2026-04-08 https://www.groupelslpharma.com/actualites-article/juno-otc-acquisition 2026-01-06 https://www.groupelslpharma.com/actualites-article/groupe-lsl-pharma-cl%C3%B4ture-un-placement-de-10-m%24-par-l%E2%80%99interm%C3%A9diaire-de-courtiers-sur-un-placement-total-de-12-m%24-et-conclut-une-entente-d%C3%A9finitive-pour-l'acquisition-de-juno-otc- 2026-01-06 https://www.groupelslpharma.com/actualites-article/acquisition-%26-private-placement 2025-12-18 https://www.groupelslpharma.com/actualites-article/acquisition-et-placement-priv%C3%A9 2025-12-18 https://www.groupelslpharma.com/actualites-article/lsl-group-pharma-announces-its-financial-results-for-q3-25 2025-11-20 https://www.groupelslpharma.com/actualites-article/groupe-lsl-annonce-ses-r%C3%A9sultats-pour-le-t3-2025 2025-11-20 https://www.groupelslpharma.com/actualites-article/une-cinqui%C3%A8me-filiale-pour-groupe-lsl-pharma! 2025-11-18 https://www.groupelslpharma.com/actualites-article/lsl-pharma-group-completes-the-acquisition-of-laboratoire-du-var 2025-11-18 https://www.groupelslpharma.com/actualites-article/health-canada-approval-for-six-new-products 2025-10-28 https://www.groupelslpharma.com/actualites-article/approbation-de-sant%C3%A9-canada-pour-6-nouveaux-produits 2025-10-28 https://www.groupelslpharma.com/actualites-article/appointments-to-the-board-of-administration%3D%3D%3D%3D%3D%3D%3D%3D 2025-10-16 https://www.groupelslpharma.com/actualites-article/nomination-au-conseil-d'administration 2025-10-16 https://www.groupelslpharma.com/actualites-article/un-nouveau-placement-priv%C3%A9-pour-groupe-lsl-pharma 2025-09-03 https://www.groupelslpharma.com/actualites-article/a-new-private-placement-for-lsl-pharma-group 2025-09-03 https://www.groupelslpharma.com/actualites-article/groupe-lsl-pharma-annonce-des-revenus-records 2025-11-20 https://www.groupelslpharma.com/actualites-article/groupe-lsl-pharma-annonce-des-revenus-records 2025-08-25 https://www.groupelslpharma.com/actualites-article/redemption-of-11%25-unsecur 2025-07-03 https://www.groupelslpharma.com/actualites-article/rachat-de-d%C3%A9bentures-convertibles 2025-07-03 https://www.groupelslpharma.com/actualites-article/financing-of-%2417.5-millions-for-lsl-pharma 2025-06-27 https://www.groupelslpharma.com/actualites-article/nouveau-financement-de-17%2C5-millions-%24-pour-groupe-lsl-pharma 2025-06-27 https://www.groupelslpharma.com/actualites-article/lsl-pharma-annouces 2025-05-29 https://www.groupelslpharma.com/actualites-article/groupe-lsl-pharma- 2025-05-29 https://www.groupelslpharma.com/actualites-article/en-actualites-article-speaker-2025-bloom-burton 2025-04-30 https://www.groupelslpharma.com/actualites-article/conf%C3%A9rencier-%C3%A0-la-2025-bloom-burton-%26-co. 2025-04-29 https://www.groupelslpharma.com/actualites-article/interest-payment-on-debentures 2025-04-29 https://www.groupelslpharma.com/actualites-article/paiement-d'int%C3%A9r%C3%AAts-sur-d%C3%A9bentures 2025-04-24 https://www.groupelslpharma.com/actualites-article/sales-of-new-products-for-q4-25 2025-04-03 https://www.groupelslpharma.com/actualites-article/commercialisation-de-nouveaux-produits-q4-25 2025-04-03 https://www.groupelslpharma.com/actualites-article/appointment-to-the-board-of-directors 2025-04-01 https://www.groupelslpharma.com/actualites-article/nomination-au-conseil-d'administration 2025-04-01 https://www.groupelslpharma.com/actualites-article/article-in-la-presse 2025-03-06 https://www.groupelslpharma.com/actualites-article/article-la-presse- 2025-03-06 https://www.groupelslpharma.com/actualites-article/un-nouveau-pr%C3%AAt-%C3%A0-terme-pour-groupe-lsl-pharma 2024-12-23 https://www.groupelslpharma.com/actualites-article/lsl-pharma-group-secures-a-new-%245.0-million-term-loan 2024-12-23 https://www.groupelslpharma.com/actualites-article/new-acquisition-for-lsl-pharma-group 2024-12-18 https://www.groupelslpharma.com/actualites-article/groupe-lsl-pharma-accro%C3%AEt-ses-activit%C3%A9s-en-acqu%C3%A9rant-dermolab- 2024-12-18 https://www.groupelslpharma.com/actualites-article/groupe-lsl-pharma-annonce-ses-r%C3%A9sultats-financiers-du-q3-24- 2024-11-25 https://www.groupelslpharma.com/actualites-article/lsl-pharma-group-announces-its-fiscal-q3-24-results 2024-11-25 https://www.groupelslpharma.com/actualites-article/new-international-clients-and-production-capacity-increase-for-steri-med 2024-11-06 https://www.groupelslpharma.com/actualites-article/nouveaux-clients-internationaux-et-augmentation-de-la-capacit%C3%A9-de-production-de-steri-med 2024-11-06 https://www.groupelslpharma.com/actualites-article/first-interest-payment-on-convertible-debentures 2024-10-28 https://www.groupelslpharma.com/actualites-article/premier-paiment-d'int%C3%A9r%C3%AAts-sur-d%C3%A9bentures-convertibles 2024-10-28 https://www.groupelslpharma.com/actualites-article/change-of-auditors-and-grant-of-options 2024-09-26 https://www.groupelslpharma.com/actualites-article/changement-d'auditeur-et-octroi-d'options 2024-09-26 https://www.groupelslpharma.com/actualites-article/lsl-pharma-group-announces-its-results-for-q2-2024 2024-08-27 https://www.groupelslpharma.com/actualites-article/groupe-lsl-pharma-annonce-ses-r%C3%A9sultats-du-t2-2024 2024-08-27 https://www.groupelslpharma.com/actualites-article/cl%C3%B4ture-de-la-deuxi%C3%A8me-et-derni%C3%A8re-tranche-de-son-placement-priv%C3%A9 2024-07-15 https://www.groupelslpharma.com/actualites-article/closing-of-second-and-final-tranche-of-private-placement 2024-07-14 https://www.groupelslpharma.com/actualites-article/lsl-group-annual-general-and-special-meeting- 2024-07-03 https://www.groupelslpharma.com/actualites-article/assembl%C3%A9e-g%C3%A9n%C3%A9rale-annuelle-et-extraordinaire-de-groupe-lsl-pharma 2024-07-03 https://www.groupelslpharma.com/actualites-article/non-brokered-private-placement 2024-07-01 https://www.groupelslpharma.com/actualites-article/placement-priv%C3%A9-sans-interm%C3%A9diaire 2024-07-01 https://www.groupelslpharma.com/actualites-article/lsl-pharma-groupe-acquires-virage-sant%C3%A9 2024-06-18 https://www.groupelslpharma.com/actualites-article/groupe-lsl-pharma-fait-l'acquisition-de-virage-sant%C3%A9 2024-06-18 https://www.groupelslpharma.com/actualites-article/lsl-pharma-retains-the-services-of-red-cloud-securities 2024-06-11 https://www.groupelslpharma.com/actualites-article/groupe-lsl-retient-les-services-de-red-cloud-securities 2024-06-11 https://www.groupelslpharma.com/actualites-article/un-nouveau-placement-priv%C3%A9-pour-groupe-lsl-pharma 2024-06-06 https://www.groupelslpharma.com/actualites-article/a-new-private-placement-for-lsl-pharma-group 2024-06-05 https://www.groupelslpharma.com/actualites-article/lsl-pharma-group-announces-q1-2024-results 2024-06-05 https://www.groupelslpharma.com/actualites-article/groupe-lsl-annonce-ses-r%C3%A9sultats-du-q1-2024 2024-05-30 https://www.groupelslpharma.com/actualites-article/listing-of-debentures-on-the-tsxv 2024-05-22 https://www.groupelslpharma.com/actualites-article/inscription-de-d%C3%A9bentures-sur-la-bourse-de-croissance-tsx 2024-05-22 https://www.groupelslpharma.com/actualites-article/binding-agreement-to-acquire-a-competitor 2024-06-10 https://www.groupelslpharma.com/actualites-article/entente-de-principe-pour-l'acquisition-d'un-concurrent 2024-05-06 https://www.groupelslpharma.com/actualites-article/2023-results 2024-05-01 https://www.groupelslpharma.com/actualites-article/r%C3%A9sultats-de-2023 2024-05-01 https://www.groupelslpharma.com/actualites-article/%243.8-million-for-the-final-tranche-of-the-private-placement 2024-04-25 https://www.groupelslpharma.com/actualites-article/3%2C8-m%24-pour-la-derni%C3%A8re-tranche-du-placement-priv%C3%A9 2024-04-25 https://www.groupelslpharma.com/actualites-article/addition-of-new-members-to-the-bod 2024-04-25 https://www.groupelslpharma.com/actualites-article/ajout-de-nouveaux-membres-au-conseil-d'administration 2024-04-25 https://www.groupelslpharma.com/actualites-article/upsizing-of-our-private-placement 2024-04-12 https://www.groupelslpharma.com/actualites-article/augmentation-de-notre-placement-priv%C3%A9 2024-04-12 https://www.groupelslpharma.com/actualites-article/bloom-burton-%26-co.-conference 2024-04-09 https://www.groupelslpharma.com/actualites-article/conf%C3%A9rence-bloom-burton-%26-co. 2024-04-09 https://www.groupelslpharma.com/actualites-article/6.44-m%24-private-placement-for-lsl-pharma-group- 2024-04-09 https://www.groupelslpharma.com/actualites-article/financement-de-6%2C44-m-%24-pour-groupe-lsl-pharma 2024-03-19 https://www.groupelslpharma.com/actualites-article/luc-mainville-joins-lsl-pharma-group! 2023-12-19 https://www.groupelslpharma.com/actualites-article/luc-mainville-rejoint-groupe-lsl-pharma! 2023-12-19 https://www.groupelslpharma.com/actualites-article/lsl-pharma-group-announces-private-placement 2023-11-27 https://www.groupelslpharma.com/actualites-article/new-plant-for-lsl-laboratory-inc. 2023-11-27 https://www.groupelslpharma.com/actualites-article/lsl-pharma-group-joins-the-toronto-stock-exchange-(tsxv) 2023-11-27 https://www.groupelslpharma.com/actualites-article/new-financing-for-lsl-group-pharma! 2023-11-27 https://www.groupelslpharma.com/actualites-article/new-customers-and-orders-for-lsl! 2023-11-27 https://www.groupelslpharma.com/actualites-article/exclusive-distribution-agreement-in-the-u.s. 2023-11-27 https://www.groupelslpharma.com/actualites-article/groupe-lsl-chooses-paradox-public-relations 2023-11-27 https://www.groupelslpharma.com/actualites-article/nouveau-financement-pour-le-groupe-lsl-pharma-! 2023-11-24 https://www.groupelslpharma.com/actualites-article/nouveaux-clients-et-nouvelles-commandes-pour-lsl! 2023-11-24 https://www.groupelslpharma.com/actualites-article/groupe-lsl-choisit-relations-publiques-paradox 2023-11-24 https://www.groupelslpharma.com/actualites-article/accord-de-distribution-exclusif--aux-usa 2023-11-24 https://www.groupelslpharma.com/actualites-article/groupe-lsl-pharma-rejoint-la-bourse-de-toronto-(tsxv) 2023-11-24 https://www.groupelslpharma.com/actualites-article/nouvelle-usine-pour-laboratoire-lsl-inc.- 2023-11-24 https://www.groupelslpharma.com/actualites-article/le-groupe-lsl-pharma-annonce-un-placement-priv%C3%A9 2023-11-24